Based on the experimental results mentioned above, we assumed that the expressions of CTDSPL and TRIB2 decrease in AML patients at diagnosis and increase in those in CR, which is contrary to the expression of miR-99a. Here, TRIB2 is linked to acute myeloid leukemia.